Pharmaceuticals

Tue, 09/07/2010 - 13:10

Conba Pharma gets nod for $62 mln private placement

Shanghai. September 7. INTERFAX-CHINA - Shanghai Stock Exchange-listed Zhejiang Conba Pharmaceutical Co. Ltd. has secured approval from China Securities Regulatory Commission (CSRC) to raise a maximum of RMB 423 million ($62.31 million) through a private placement, the company announced Sept. 6.

This article is only accessible to Interfax subscribers. To gain access to this article, as well similar in-depth articles and industry-specific content, please contact our sales staff by telephone (+852 2537 2262) .

Start free trial NOW